Tetrandrine enhances glucocorticoid receptor translocation possibly via inhibition of P-glycoprotein in daunorubicin-resistant human T lymphoblastoid leukemia cells

This publication has 29 references indexed in Scilit:

• P-glycoprotein Mediates Drug Resistance via a Novel Mechanism Involving Lysosomal Sequestration
  Journal of Biological Chemistry, 2013
• Current concepts in glucocorticoid resistance
  Steroids, 2012
• Treatment strategy based on targeting P-glycoprotein on peripheral lymphocytes in patients with systemic autoimmune disease
  Clinical and Experimental Nephrology, 2011
• Multidrug Resistance Reversal Agent, NSC77037, Identified with a Cell-Based Screening Assay
  SLAS Discovery, 2010
• P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil
  Archives of Biochemistry and Biophysics, 2009
• Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1®
  Biochemical Pharmacology, 2008
• Clinical relevance of the expression of P‐glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus
  Arthritis & Rheumatism, 2005
• Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance
  Cell Death & Differentiation, 2004
• Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells
  Journal of Pharmacy and Pharmacology, 2003
• Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA
  Cancer Chemotherapy and Pharmacology, 2002